11. Gender‐ and site‐specific differences of colorectal neoplasia relate to vitamin D. Issue 11 (2nd October 2014) Authors: Aigner, E.; Stadlmayr, A.; Huber‐Schönauer, U.; Zwerina, J.; Husar‐Memmer, E.; Niederseer, D.; Trauner, M.; Heuberger, A.; Hohla, F.; Schett, G.; Patsch, W.; Datz, C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 11/12(2014) Page Start: 1341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. Issue 4 (29th June 2018) Authors: Mandorfer, M.; Scheiner, B.; Stättermayer, A. F.; Schwabl, P.; Paternostro, R.; Bauer, D.; Schaefer, B.; Zoller, H.; Peck‐Radosavljevic, M.; Trauner, M.; Reiberger, T.; Ferenci, P.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 4(2018) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses. Issue 6 (16th July 2015) Authors: Mandorfer, M.; Kozbial, K.; Freissmuth, C.; Schwabl, P.; Stättermayer, A. F.; Reiberger, T.; Beinhardt, S.; Schwarzer, R.; Trauner, M.; Ferlitsch, A.; Hofer, H.; Peck‐Radosavljevic, M.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 6(2015) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease. Issue 1 (7th November 2016) Authors: Schwabl, P.; Mandorfer, M.; Steiner, S.; Scheiner, B.; Chromy, D.; Herac, M.; Bucsics, T.; Hayden, H.; Grabmeier‐Pfistershammer, K.; Ferlitsch, A.; Oberhuber, G.; Trauner, M.; Peck‐Radosavljevic, M.; Reiberger, T. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 1(2017) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Long-term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression. (March 2021) Authors: Bowlus, C.L.; Trauner, M.; Liberman, A.; Malecha, E.; MacConell, L.; Kremer, A.E.; Nevens, F.; Floreani, A. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Non-alcoholic steatohepatitis is reflected by levels of systemic soluble TREM2 and limited by the recruitment of TREM2-positive macrophages to areas of lipid-induced tissue damage. (August 2022) Authors: Porsch, F.; Kiss, M.G.; Rajčić, D.; Papac-Milicevic, N.; Goederle, L.; Hladik, A.; Derdak, S.; Shaw, L.E.; Heintz, L.; Paternostro, R.; Farlik, M.; Knapp, S.; Krawczyk, M.; Trauner, M.; Bilban, M.; Wolf, D.; Binder, C.J.; Hendrikx, T. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes. (March 2023) Authors: Pennisi, G.; Enea, M.; Falco, V.; Aithal, G.P.; Palaniyappan, N.; Yilmaz, Y.; Boursier, J.; Cassinotto, C.; de Lédinghen, V.; Chan, W.K.; Mahadeva, S.; Eddowes, P.; Newsome, P.; Karlas, T.; Wiegand, J.; Wong, V. Wai-Sun; Schattenberg, J.M.; Labenz, C.; Kim, W.; Lee, M.S. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. OC.04.7 LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION. (September 2021) Authors: Floreani, A.; Bowlus, C.L.; Trauner, M.; Malecha, E.; Kremer, A.E.; Nevens, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Pathophysiology of bile acids affects liver regeneration in patients undergoing liver resection. (2020) Authors: Pereyra, D.; Fuchs, Claudia; Trauner, M.; Starlinger, P. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Pathophysiology of Bile Acids Affects Liver Regeneration in Patients Undergoing Liver Resection. (2021) Authors: Sorz, T.; Pereyra, D.; Santol, J.; Fritsch, F.; Ammonn, D.; Fuchs, C.; Trauner, M.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗